Christopher Downs

Insider Reports History

Entity
Individual
Location
31700 Research Park Drive, Madison Heights, MI
Signature
/s/ Christopher Downs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Downs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Chief Financial Officer Common stock 103K $31K $0.30 Feb 1, 2024 Direct
EBET, Inc. Director Restricted Stock Units 75K $7.5K $0.10 Feb 9, 2023 Direct
EBET, Inc. Director Common Stock 6.3K $630 $0.10 Feb 9, 2023 Direct
CNS Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 242 $72.50 $0.30 Apr 8, 2024 Direct
CNS Pharmaceuticals, Inc. Chief Financial Officer Series B Warrant to purchase common stock 162K Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Chief Financial Officer Series A Warrant to purchase common stock 94.9K Feb 1, 2024 Direct
CNS Pharmaceuticals, Inc. Chief Financial Officer Option to purchase common stock 202 Apr 8, 2024 Direct

Insider Reports Filed by Christopher Downs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNSP CNS Pharmaceuticals, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Feb 1, 2024 3 $20K 4 Feb 6, 2024 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Aug 22, 2023 1 $34.2K 4 Aug 23, 2023 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Apr 28, 2023 2 $0 4 May 1, 2023 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Apr 17, 2023 1 $9.92K 4 Apr 18, 2023 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Chief Financial Officer
EBET EBET, Inc. Feb 9, 2023 2 $0 4 Feb 10, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Apr 28, 2022 1 $0 4 Apr 29, 2022 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Mar 11, 2022 1 $10.2K 4 Mar 14, 2022 Chief Financial Officer
EBET Esports Technologies, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Director
CNSP CNS Pharmaceuticals, Inc. Dec 6, 2021 1 $4.7K 4 Dec 7, 2021 Chief Financial Officer
CNSP CNS Pharmaceuticals, Inc. Nov 19, 2021 1 $5.19K 4 Nov 22, 2021 Chief Financial Officer